World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Qi XS, Bai M, Fan DM. Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis. World J Gastroenterol 2014; 20(32): 11463-11466 [PMID: 25170238 DOI: 10.3748/wjg.v20.i32.11463]
URL:	https://www.wjgnet.com/1007-9327/full/v20/i32/11463.htm

(313) (337) (0) (0) (0) (5143) (25)

Number	Citing Articles
1	Jie Chen, Xiao Qing Zeng, Li Li Ma, Xiao Quan Huang, Yu Jen Tseng, Jian Wang, Tian Cheng Luo, Shi Yao Chen. Long‐term efficacy of endoscopic ligation plus cyanoacrylate injection with or without sclerotherapy for variceal bleeding. Journal of Digestive Diseases 2016; 17(4) doi: 10.1111/1751-2980.12331
2	Junyuan Zhu, Yifu Xia, Xiao Liu, Chunqing Zhang. Preventing variceal rebleeding in cirrhotic patients with portal vein thrombosis: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2024; 39(4) doi: 10.1111/jgh.16489
3	Anderson Brito‐Azevedo, Ubiratan Cassano‐Santos. Non‐Selective Beta‐Blockers and Portal Vein Thrombosis in Cirrhosis: Before We Sound the Alarm. Liver International 2026; 46(7) doi: 10.1111/liv.70704
4	Yong Lv, Xingshun Qi, Chuangye He, Zhengyu Wang, Zhanxin Yin, Jing Niu, Wengang Guo, Wei Bai, Hongbo Zhang, Huahong Xie, Liping Yao, Jianhong Wang, Tao Li, Qiuhe Wang, Hui Chen, Haibo Liu, Enxing Wang, Dongdong Xia, Bohan Luo, Xiaomei Li, Jie Yuan, Na Han, Ying Zhu, Jielai Xia, Hongwei Cai, Zhiping Yang, Kaichun Wu, Daiming Fan, Guohong Han. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut 2018; 67(12) doi: 10.1136/gutjnl-2017-314634
5	Filipe Nery. Vascular Disorders of the Liver. 2022; doi: 10.1007/978-3-030-82988-9_8
6	Ousmane Sow, Dramane Soro, Regis Lah Bi, Abdoulatif Yaogo, Amadou Ouattara. Portal Vein Thrombosis in Cirrhotic Patients: Risk Factors Involved. Open Journal of Gastroenterology 2025; 15(09) doi: 10.4236/ojgas.2025.159047
7	Jaume Bosch, Annalisa Berzigotti. Letter: nonselective beta‐blockers, endoscopic therapy and portal vein thrombosis in cirrhosis. Alimentary Pharmacology & Therapeutics 2019; 49(10) doi: 10.1111/apt.15236
8	Xiangbo Xu, Shixue Xu, Massimo Primignani, Valerio De Stefano, Yanglan He, Fangfang Yi, Xiaozhong Guo, Dominique Valla, Xingshun Qi. Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study. Advances in Therapy 2020; 37(4) doi: 10.1007/s12325-020-01250-z
9	Zhenqian Wang, Jiawen Lu, Jingyi Hu. Association between antihypertensive drugs and hepatocellular carcinoma: A trans‐ancestry and drug‐target Mendelian randomization study. Liver International 2023; 43(6) doi: 10.1111/liv.15566
10	Nicholas Bartell, Bandar Al-Judaibi. Beta-blocker therapy in refractory ascites. Saudi Journal of Gastroenterology 2022; 28(2) doi: 10.4103/sjg.sjg_87_22
11	Leona von Köckritz, Andrea De Gottardi, Jonel Trebicka, Michael Praktiknjo. Portal vein thrombosis in patients with cirrhosis. Gastroenterology Report 2017; 5(2) doi: 10.1093/gastro/gox014
12	Filipe Nery, Sofia Correia, Carlos Macedo, Judit Gandara, Vítor Lopes, Diana Valadares, Sofia Ferreira, João Oliveira, Manuel Teixeira Gomes, Raquel Lucas, Pierre‐Emmanuel Rautou, Helena Pessegueiro Miranda, Dominique Valla. Nonselective beta‐blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study. Alimentary Pharmacology & Therapeutics 2019; 49(5) doi: 10.1111/apt.15137
13	Xiangbo Xu, Xiaozhong Guo, Frank Tacke, Xiaodong Shao, Xingshun Qi. Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence. Therapeutic Advances in Chronic Disease 2019; 10 doi: 10.1177/2040622319862693
14	Sara Blasco-Algora, José Masegosa-Ataz, Sonia Alonso, Maria-Luisa Gutiérrez, Conrado Fernández-Rodriguez. Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function. BMJ Open Gastroenterology 2016; 3(1) doi: 10.1136/bmjgast-2016-000104
15	Humberto C. Gonzalez, Stuart C. Gordon, Sheri Trudeau, Trueman Wu, Lora Rupp, Christina Melkonian, Mark A. Schmidt, Yihe G. Daida, Amandeep K. Sahota, Christopher L. Bowlus, Mei Lu. Impact of Disease‐Specific Treatment and Non‐Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC. Liver International 2026; 46(5) doi: 10.1111/liv.70628
16	Mahmoud Saad Berengy, Elsayed Mohamed Abd El-Hamid Hassan, Amal H. Ibrahim, Eman F. Mohamed. Safety and efficacy of transjugular intrahepatic portosystemic shunts vs endoscopic band ligation plus propranolol in patients with cirrhosis with portal vein thrombosis: a systematic review and meta-analysis. Journal of Gastrointestinal Surgery 2024; 28(3) doi: 10.1016/j.gassur.2023.12.031
17	Xingshun Qi, Hongyu Li, Xu Liu, Hui Yao, Guohong Han, Fengrong Hu, Lichun Shao, Xiaozhong Guo. Novel insights into the development of portal vein thrombosis in cirrhosis patients. Expert Review of Gastroenterology & Hepatology 2015; 9(11) doi: 10.1586/17474124.2015.1083856
18	A. Kumar, P. Sharma, A. Arora. Review article: portal vein obstruction – epidemiology, pathogenesis, natural history, prognosis and treatment. Alimentary Pharmacology & Therapeutics 2015; 41(3) doi: 10.1111/apt.13019
19	Mohammad Amin Fallahzadeh, Sumeet K Asrani, Elliot B Tapper, Giovanna Saracino, Robert S Rahimi. Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis. World Journal of Clinical Cases 2022; 10(23): 8097-8106 doi: 10.12998/wjcc.v10.i23.8097 Abstract(1027) \| Core Tip(984) \| Full Article(HTML)(3637) \| Full Article (PDF)-1933K(393) \| Full Article (Word)-209K(69) \| Audio-821K(9) \| Peer-Review Report-188K(173) \| Answering Reviewers-93K(187) \| Supplementary Material-192K(172) \| Times Cited (5) \| Total Visits (5309) \| Open
20	Ki Tae Yoon, Hongqun Liu, Samuel S. Lee. β-blockers in advanced cirrhosis: More friend than enemy. Clinical and Molecular Hepatology 2021; 27(3) doi: 10.3350/cmh.2020.0234
21	Xing-Shun Qi, Yong-Xin Bao, Ming Bai, Wen-Da Xu, Jun-Na Dai, Xiao-Zhong Guo. Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis. World Journal of Gastroenterology 2015; 21(10): 3100-3108 doi: 10.3748/wjg.v21.i10.3100 Abstract(1397) \| Core Tip(1429) \| Full Article(HTML)(6559) \| Full Article (PDF)-1218K(879) \| Full Article (Word)-489K(334) \| Peer-Review Report-110K(443) \| Answering Reviewers-114K(336) \| Times Cited (48) \| Total Visits (8845) \| Open
22	Huiwen Guo, Jiangqiang Xiao, Yi Wang, Ming Zhang, Yuzheng Zhuge, Feng Zhang, Barbara Azzimonti. Increase in Free Hepatic Venous Pressure Response to Beta‐Blockers Predicts Variceal Bleeding in Cirrhotic Patients. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/5587566
23	Wen Tang, Yu Wang, Xinyan Zhao, Xiaoming Wang, Tao Zhang, Xiaojuan Ou, Weiling Shou, Hong You, Jidong Jia. Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis. European Journal of Gastroenterology & Hepatology 2015; 27(6) doi: 10.1097/MEG.0000000000000352
24	Ishtiaq Ahmad, Shivam Singla, Ali Nasir, Bhavna Singla, Ajay ., Sunita Kumawat, Sajid Abbas. Effect of Non-selective Beta-Blockers on the Prevention of Decompensation in Compensated Cirrhosis: A Systematic Review. Cureus 2026; doi: 10.7759/cureus.103468
25	Xiangbo Xu, Xiaozhong Guo, Valerio De Stefano, Gilberto Silva-Junior, Hemant Goyal, Zhaohui Bai, Qingchun Zhao, Xingshun Qi. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis. Hepatology International 2019; 13(4) doi: 10.1007/s12072-019-09951-6